Global Practices in Cardiac Imaging for Cardiac Sarcoidosis

作者：Tahir S Kafil, Manuel L. Ribeiro Neto, Marc A. Judson, Leslie T. Cooper, Jordana Kron, Jan C. Grutters, David Birnie, Ronald Witteles, Emer Joyce, Edward Jeremy Miller, Amit Patel, Daniel A. Culver, Christine Jellis, Tahir S. Kafil, Nabeel Hamzeh, Leslie Cooper, Kory Lavine, Fabio Arimura, Arthur Yee, Nisha A. Gilotra, W.H. Wilson Tang, Matthew C. Baker, Gerard Giblin, Leila Laroussi, Marc Judson, Chetan Shenoy, Rob Beanlands, Amanda Vest, Jordana Kron, David Prior, Calambur Narasimhan, Francis Murgatroyd, Wim Wuyts, Wael Jaber, Divya Patel, Amit Patel, Daniel Sado, D. Ian Paterson, Aamer Syed, Sanjay Divakaran, Vasilis Kouranos, Terrence Ruddy, A.M.D. Renske Vorselaars, Robert P. Baughman, Toshiyuki Nagai, Mareye Voortman, Ron Blankstein, Indu Poornima, Cori E. Russell, Mario Senechal, Thomas Plante, Martin Swaans, Christine Jellis, Tom Callahan, Paul Kim, Girish Dwivedi, Lisa Maier, Toshiyuki Yano, Debabrata Bandyopadhyay, James Galloway, Jonathan Chrispin, Kenji Yodogawa, Jan M. Griffin, Yogita Rochlani, Line Kemeyou, Elliott Crouser, W. Ennis James, Kosuke Nakasuka, Bettina Heidecker, Jan C. Grutters, Ronald Witteles, Roger Allen, Laura Murphy, Mustafa Toma, Marcel Veltkamp, Amanda Varnava, Fatima Akdim, Genevieve Giraldeau, Felix Ayala-Parades, Richard K. Cheng, Edward S. Chen, Paul Cremer, Nikolaos Tzemos, Marloes Huitema, Paolo Spagnolo, Manuel Ribeiro, Kengo Kusano, Emer Joyce, Kelly Arps, Farooq H. Sheikh, Matthias Friedrich, Edward Miller, Vanessa Ferreira, David Birnie, Marco Post, Jukka Lehtonen, Patompong Ungprasert, Daniel Culver, Joanna Porter, Athol Wells, Ziad Taimeh, Bekir Karakaya · 发表于：JACC. Cardiovascular imaging · 年份：2025 · DOI：10.1016/j.jcmg.2025.02.010 · 被引用次数：10 · 研究领域：Sarcoidosis and Beryllium Toxicity Research、Pericarditis and Cardiac Tamponade、Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

BACKGROUND: Cardiac imaging is a cornerstone in the initial diagnosis, management, and follow-up of cardiac sarcoidosis. However, ordering thresholds, access, and follow-up imaging vary across the globe. OBJECTIVES: A Delphi study was conducted to define areas of consensus and areas requiring further study in the use of cardiac imaging in suspected or established cardiac sarcoidosis. METHODS: An international, multidisciplinary panel of experts in cardiac sarcoidosis completed a modified 2-round Delphi study. The study evaluated clinical decision making regarding the use of cardiac imaging, including indication thresholds, interpretation, and interval follow-up imaging. Consensus was defined a priori as ≥70% agreement or disagreement. RESULTS: F-fluorodeoxyglucose (FDG) positron emission tomography was an important co-primary modality with cardiac magnetic resonance (CMR) for initial diagnosis. If CMR was the first test, there was consensus to proceed to FDG-positron emission tomography after any abnormal CMR result or even after normal CMR result in the setting of moderate or high pretest probability for cardiac sarcoidosis. There was consensus that late gadolinium enhancement quantification was important, but there was no consensus on the threshold of risk or on how best to quantify late gadolinium enhancement. Similarly, reduction in FDG uptake was an important factor in guiding treatment response, but there was no consensus on how to best quantify FDG uptake or what const...